Drug Discovery Informatics Market Report Research Report - Global Forecast Till 2027

Global Drug Discovery Informatics Market Share, Trends And Size Analysis By Market Research Report: Information By Product (Discovery Informatics, Development Informatics), Mode (In-House Informatics), Service (Clinical Trial Data Management, Molecular Modeling), & End User—Forecast Till 2027

ID: MRFR/HC/6360-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


Global drug discovery informatics market is expected to register a healthy CAGR over the forecast period. The market held a market value of USD 1,680.6 million in 2017 and is projected to grow at a CAGR of 11.5% during the forecast period. Drug discovery and development is a highly intricate process requiring the generation of very large amounts of data and information. Large amounts of data are generated using a variety of innovative technologies, and the limiting step is accessing, searching and integrating this data. The current approaches to collect information from various sources have been dealt with in some cases where the data types are very least well-defined or largely homogeneous. However, the world is on the verge of a new age of drug discovery informatics, the methods and approaches in which are dealing with gathering information from data and knowledge from information are undergoing a paradigm shift. Mining and integration of domain-specific information such as chemical and genomic data will continue to develop in the near future. Drug discovery is a functional process in pharmaceutical and biotechnology companies. It involves different steps and procedures that depend on in-silico tools for reducing the complexity of a process. Some of the factors driving the market growth are a rising worldwide focus on drug discovery, growing need to control drug discovery and development costs, growth in R&D expenditure, and increasing burden of chronic diseases. For instance, according to the World Health Organization (WHO), in 2001, chronic diseases contributed around 60% of the 56.5 million total reported deaths across the world and approximately 46% of the global burden of disease, which is projected that, by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide. On the other hand, high pricing and setup cost of informatics software is anticipated to restrict the market growth during the forecast period.


Segmentation


The global drug discovery informatics market has been segmented into product, mode, service, end user, and region.


By product, the market has been segmented into discovery informatics and development informatics.


On the basis of mode, the market has been divided into in-house informatics and outsourced informatics. 


By service, the market has been classified into sequencing and target data analysis, docking, molecular modeling, clinical trial data management, and others. The sequencing and target data analysis segment is expected to dominate the market over the forecast period due to rising application of informatics solutions in targeted analysis and a large amount of data generated during the drug discovery process.


Based on end user, the market has been categorized into pharmaceutical and biotechnology industries, contract research organizations (CROs), and others.


The global drug discovery informatics market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The drug discovery informatics market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. 


The European drug discovery informatics market has been segmented into Western Europe and Eastern Europe. The Western Europe drug discovery informatics market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The drug discovery informatics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The drug discovery informatics market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key players


Few of the spearheads in the global drug discovery informatics market are Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault Systèmes.


Regional Market Summary
Drug Discovery Informatics Market Share

Global
Drug Discovery Informatics Market Share (%), by Region, 2017

Geographically, the Americas spearheaded the global drug discovery informatics market in 2017. This is owing to the presence of major market value participants (Thermo Fisher Scientific, Inc., PerkinElmer, Inc., International Business Machines Corporation) and sophisticated healthcare infrastructure, flourishing pharmaceutical and biotechnology industries, and developments of next-generation sequencing and chemical laboratories in the US and Canada.


Europe would be the second largest contributor in terms of value during next five years attributed to the financial support provided by the government for research and development in drugs, growth in the therapeutic discovery ventures and activities carried out by research and academic institutes, universities, and other centers.


Asia-Pacific is expected to represent profitable market growth from 2018 to 2023 owing to growing geriatric population coupled with rising prevalence of chronic diseases, increasing awareness and high adoption of drug discovery informatics, and surging number of clinical trials studies in the region. For instance, Asia-Pacific offers a substantial cost saving advantage, with savings ranging from 50% to 80% of the cost in comparison with the developed nations, thereby resulting into a rise in the volume of clinical trials being conducted in this region.


The drug discovery informatics market in the Middle East & Africa would witness the modest market growth rate from 2018 to 2023. The Middle East and North Africa (MENA) region constitutes 2% of global pharmaceutical sales. Rampant growth in population has fueled drug demand especially for higher-yield pharmaceutical products attracting the attention of multinational pharmaceutical companies in the MENA region.


Global Drug Discovery Informatics Market, by Product



  • Discovery Informatics

  • Development Informatics


Global Drug Discovery Informatics Market, by Mode



  • In-house Informatics

  • Outsourced Informatics


Global Drug Discovery Informatics Market, by Service



  • Sequencing and Target Data Analysis

  • Docking

  • Molecular Modeling

  • Clinical Trial Data Management

  • Others


Global Drug Discovery Informatics Market, by End User



  • Pharmaceutical and Biotechnology Industries

  • Contract Research Organizations (CROs)

  • Others


Global Drug Discovery Informatics Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America



  • Europe

    • Western Europe

    • Germany

    • France

    • Italy

    • Spain

    • UK

    • Rest of Western Europe



  • Eastern Europe

    • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




Global Drug Discovery Informatics Market, by Key Players



  • Thermo Fisher Scientific, Inc.

  • PerkinElmer, Inc.

  • Certara, L.P.

  • Infosys Limited

  • Novo Informatics Pvt. Ltd.

  • Collaborative Drug Discovery Inc.

  • Selvita

  • Charles River Laboratories, Inc.

  • International Business Machines Corporation

  • Jubilant Life Sciences Ltd.

  • IO Informatics, Inc.

  • GVK Biosciences Private Limited

  • Dassault Systèmes


Intended Audience



  • Drug discovery informatics providers

  • Venture capitalists

  • Pharmaceutical companies

  • Biotechnology companies

  • Research and academic institutes

  • Government associations

  • Association and government bodies

  • Market research and consulting service providers

  • Corporate entities



Frequently Asked Questions (FAQ) :


Drug discovery informatics market was valued at more than USD 1.6 billion in 2017.

Drug discovery informatics market is expected to exhibit a solid 11.5% CAGR over the forecast period from 2018 to 2023.

The increasing investment in drug discovery applications is likely to be a major driver for the global drug discovery informatics market.

The Americas spearhead the global drug discovery informatics market, followed by Europe.

Leading players in the drug discovery informatics market include Thermo Fisher Scientific, Infosys, Certara, Selvita, and Jubilant Life Sciences, among others.

Table of Contents:

Chapter 1 Report Prologue

Chapter 2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Detection Technique Trends & Assessment

Chapter 5 Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6 Global Drug Discovery Informatics Market, by Product

6.1 Introduction

6.2 Discovery Informatics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Development Informatics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7 Global Drug Discovery Informatics Market, by Mode

7.1 Introduction

7.2 In-House Informatics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Outsourced Informatics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 8 Global Drug Discovery Informatics Market, by Service

8.1 Introduction

8.2 Sequencing and Target Data Analysis

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3 Docking

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4 Molecular Modeling

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.5 Clinical Trial Data Management

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.6 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 9 Global Drug Discovery Informatics Market, by End User

9.1 Introduction

9.2 Pharmaceutical and Biotechnology Industries

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.3 Contract Research Organizations (CROs)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.4 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 10 Global Drug Discovery Informatics Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Developments & Strategies

Chapter 12 Company Profiles

12.1 Thermo Fisher Scientific, Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financial Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.1.6 Key Strategies

12.2 PerkinElmer, Inc.

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.2.6 Key Strategies

12.3 Certara, L.P.

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Developments

12.3.5 SWOT Analysis

12.3.6 Key Strategies

12.4 Infosys Limited

12.4.1 Company Overview

12.4.2 Product Overview

12.4.3 Financial Overview

12.4.4 Key Developments

12.4.5 SWOT Analysis

12.4.6 Key Strategies

12.5 Novo Informatics Pvt. Ltd.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial Overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.5.6 Key Strategies

12.6 Collaborative Drug Discovery Inc.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.6.6 Key Strategies

12.7 Selvita

12.7.1 Company Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.7.6 Key Strategies

12.8 Charles River Laboratories, Inc.

12.8.1 Company Overview

12.8.2 Product Overview

12.8.3 Financial Overview

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.8.6 Key Strategies

12.9 International Business Machines Corporation

12.9.1 Company Overview

12.9.2 Product Overview

12.9.3 Financial Overview

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.9.6 Key Strategies

12.10 Jubilant Life Sciences Ltd.

12.10.1 Company Overview

12.10.2 Product Overview

12.10.3 Financial Overview

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.10.6 Key Strategies

12.11 IO Informatics, Inc.

12.11.1 Company Overview

12.11.2 Product Overview

12.11.3 Financial Overview

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.11.6 Key Strategies

12.12 GVK Biosciences Private Limited

12.12.1 Company Overview

12.12.2 Product Overview

12.12.3 Financial Overview

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.12.6 Key Strategies

12.13 Dassault Systèmes

12.13.1 Company Overview

12.13.2 Product Overview

12.13.3 Financial Overview

12.13.4 Key Developments

12.13.5 SWOT Analysis

12.13.6 Key Strategies

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Drug Discovery Informatics Industry

Chapter 14 Appendix

LIST OF TABLES

Table 1 Global Drug Discovery Informatics Market Synopsis, 2020–2027

Table 2 Global Drug Discovery Informatics Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Drug Discovery Informatics Market, by Region, 2020–2027 (USD Million)

Table 4 Global Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 5 Global Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 6 Global Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 7 Global Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 8 North America: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 9 North America: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 10 North America Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 11 North America: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 12 US: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 13 US: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 14 US: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 15 US: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 16 Canada: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 17 Canada: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 18 Canada: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 19 Canada: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 20 Latin America: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 21 Latin America: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 22 Latin America: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 23 Latin America: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 24 Europe: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 25 Europe: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 26 Europe: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 27 Europe: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 28 Western Europe: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 29 Western Europe: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 30 Western Europe: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 31 Western Europe: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 32 Eastern Europe: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 33 Eastern Europe: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 34 Eastern Europe: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 35 Eastern Europe: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 36 Asia-Pacific: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 37 Asia-Pacific: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 38 Asia-Pacific: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 39 Asia-Pacific: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

Table 40 Middle East & Africa: Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)

Table 41 Middle East & Africa: Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)

Table 42 Middle East & Africa: Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)

Table 43 Middle East & Africa: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Drug Discovery Informatics Market

Figure 3 Segmentation Market Dynamics for Global Drug Discovery Informatics Market

Figure 4 Global Drug Discovery Informatics Market Share, by Product, 2020

Figure 5 Global Drug Discovery Informatics Market Share, by Mode, 2020

Figure 6 Global Drug Discovery Informatics Market Share, by Service, 2020

Figure 7 Global Drug Discovery Informatics Market Share, by End User, 2020

Figure 8 Global Drug Discovery Informatics Market Share, by Region, 2020

Figure 9 North America: Drug Discovery Informatics Market Share, by Country, 2020

Figure 10 Europe: Drug Discovery Informatics Market Share, by Country, 2020

Figure 11 Asia-Pacific: Drug Discovery Informatics Market Share, by Country, 2020

Figure 12 Middle East & Africa: Drug Discovery Informatics Market Share, by Country, 2020

Figure 13 Global Drug Discovery Informatics Market: Company Share Analysis, 2020 (%)

Figure 14 Thermo Fisher Scientific, Inc.: Key Financials

Figure 15 Thermo Fisher Scientific, Inc.: Segmental Revenue

Figure 16 Thermo Fisher Scientific, Inc.: Geographical Revenue

Figure 17 PerkinElmer, Inc.: Key Financials

Figure 18 PerkinElmer, Inc.: Segmental Revenue

Figure 19 PerkinElmer, Inc.: Geographical Revenue

Figure 20 Certara, L.P.: Key Financials

Figure 21 Certara, L.P.: Segmental Revenue

Figure 22 Certara, L.P.: Geographical Revenue

Figure 23 Infosys Limited: Key Financials

Figure 24 Infosys Limited: Segmental Revenue

Figure 25 Infosys Limited: Geographical Revenue

Figure 26 Novo Informatics Pvt. Ltd.: Key Financials

Figure 27 Novo Informatics Pvt. Ltd.: Segmental Revenue

Figure 28 Novo Informatics Pvt. Ltd.: Geographical Revenue

Figure 29 Collaborative Drug Discovery Inc.: Key Financials

Figure 30 Collaborative Drug Discovery Inc.: Segmental Revenue

Figure 31 Collaborative Drug Discovery Inc.: Geographical Revenue

Figure 32 Selvita: Key Financials

Figure 33 Selvita: Segmental Revenue

Figure 34 Selvita: Geographical Revenue

Figure 35 Charles River Laboratories, Inc.: Key Financials

Figure 36 Charles River Laboratories, Inc.: Segmental Revenue

Figure 37 Charles River Laboratories, Inc.: Geographical Revenue

Figure 38 International Business Machines Corporation: Key Financials

Figure 39 International Business Machines Corporation: Segmental Revenue

Figure 40 International Business Machines Corporation: Geographical Revenue

Figure 41 Jubilant Life Sciences Ltd.: Key Financials

Figure 42 Jubilant Life Sciences Ltd.: Segmental Revenue

Figure 43 Jubilant Life Sciences Ltd.: Geographical Revenue

Figure 44 IO Informatics, Inc.: Key Financials

Figure 45 IO Informatics, Inc.: Segmental Revenue

Figure 46 IO Informatics, Inc.: Geographical Revenue

Figure 47 GVK Biosciences Private Limited: Key Financials

Figure 48 GVK Biosciences Private Limited: Segmental Revenue

Figure 49 GVK Biosciences Private Limited: Geographical Revenue

Figure 50 Dassault Systèmes: Key Financials

Figure 51 Dassault Systèmes: Segmental Revenue

Figure 52 Dassault Systèmes: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.